To further clarify the molecular mechanism of the defective differentiation of HSPCs in the bone marrow of myeloma, high-throughput RNA-seq was utilized to determine the differential gene expression in CD34+ cells between MM patients and healthy donors. The gene discussed is CD34; the disease is Miyoshi myopathy.